Drugs / ABX-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06096415 | Dec 2023 → Apr 2024 | brain edema, traumatic brain injury | Abalonex, LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABX-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06096415 ↗ |
| Route | Intramuscular | “intramuscular injections” NCT06096415 ↗ |